BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 9125535)

  • 21. CTLA-4 blockade differentially influences the outcome of non-lethal and lethal Plasmodium yoelii infections.
    Lepenies B; Gaworski I; Tartz S; Langhorne J; Fleischer B; Jacobs T
    Microbes Infect; 2007 May; 9(6):687-94. PubMed ID: 17398134
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Suppression of lethal Plasmodium yoelii malaria following protective immunization requires antibody-, IL-4-, and IFN-gamma-dependent responses induced by vaccination and/or challenge infection.
    Petritus PM; Burns JM
    J Immunol; 2008 Jan; 180(1):444-53. PubMed ID: 18097046
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CD28 costimulation is required for the expression of T-cell-dependent cell-mediated immunity against blood-stage Plasmodium chabaudi malaria parasites.
    Rummel T; Batchelder J; Flaherty P; LaFleur G; Nanavati P; Burns JM; Weidanz WP
    Infect Immun; 2004 Oct; 72(10):5768-74. PubMed ID: 15385476
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Outcome of primary lethal and nonlethal Plasmodium yoelii malaria infection in BALB/c and IFN-γ receptor-deficient mice following chloroquine treatment.
    Ishih A; Kawakami C; Todoroki A; Hirai H; Ohori K; Kobayashi F
    Parasitol Res; 2013 Feb; 112(2):773-80. PubMed ID: 23180129
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immune responses to defined epitopes of the circumsporozoite protein of the murine malaria parasite, Plasmodium yoelii.
    Grillot D; Michel M; Müller I; Tougne C; Rènia L; Mazier D; Corradin G; Lambert PH; Louis JA; Del Guidice G
    Eur J Immunol; 1990 Jun; 20(6):1215-22. PubMed ID: 1695152
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MAPK phosphotase 5 deficiency contributes to protection against blood-stage Plasmodium yoelii 17XL infection in mice.
    Cheng Q; Zhang Q; Xu X; Yin L; Sun L; Lin X; Dong C; Pan W
    J Immunol; 2014 Apr; 192(8):3686-96. PubMed ID: 24634491
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expansion of the CD4-, CD8- gamma delta T cell subset in the spleens of mice during non-lethal blood-stage malaria.
    van der Heyde HC; Elloso MM; Roopenian DC; Manning DD; Weidanz WP
    Eur J Immunol; 1993 Aug; 23(8):1846-50. PubMed ID: 8344345
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mycobacterium-induced potentiation of type 1 immune responses and protection against malaria are host specific.
    Page KR; Jedlicka AE; Fakheri B; Noland GS; Kesavan AK; Scott AL; Kumar N; Manabe YC
    Infect Immun; 2005 Dec; 73(12):8369-80. PubMed ID: 16299335
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Listeria monocytogenes inoculation protects mice against blood-stage Plasmodium yoelii infection.
    Qi Z; Han X; Zhang Y; Wang J; Cao YM
    Tohoku J Exp Med; 2013 Feb; 229(2):87-96. PubMed ID: 23303295
    [TBL] [Abstract][Full Text] [Related]  

  • 30. alpha -galactosylceramide-activated Valpha 14 natural killer T cells mediate protection against murine malaria.
    Gonzalez-Aseguinolaza G; de Oliveira C; Tomaska M; Hong S; Bruna-Romero O; Nakayama T; Taniguchi M; Bendelac A; Van Kaer L; Koezuka Y; Tsuji M
    Proc Natl Acad Sci U S A; 2000 Jul; 97(15):8461-6. PubMed ID: 10900007
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dendritic cells induce immunity and long-lasting protection against blood-stage malaria despite an in vitro parasite-induced maturation defect.
    Pouniotis DS; Proudfoot O; Bogdanoska V; Apostolopoulos V; Fifis T; Plebanski M
    Infect Immun; 2004 Sep; 72(9):5331-9. PubMed ID: 15322030
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of in vivo administration of anti-IL-10 or anti-IFN-gamma monoclonal antibody on the host defense mechanism against Plasmodium yoelii yoelii infection.
    Kobayashi F; Ishida H; Matsui T; Tsuji M
    J Vet Med Sci; 2000 Jun; 62(6):583-7. PubMed ID: 10907683
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gamma interferon production is critical for protective immunity to infection with blood-stage Plasmodium berghei XAT but neither NO production nor NK cell activation is critical.
    Yoneto T; Yoshimoto T; Wang CR; Takahama Y; Tsuji M; Waki S; Nariuchi H
    Infect Immun; 1999 May; 67(5):2349-56. PubMed ID: 10225894
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Elevated levels of the Plasmodium yoelii homologue of macrophage migration inhibitory factor attenuate blood-stage malaria.
    Thorat S; Daly TM; Bergman LW; Burns JM
    Infect Immun; 2010 Dec; 78(12):5151-62. PubMed ID: 20837716
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Coinfection with nonlethal murine malaria parasites suppresses pathogenesis caused by Plasmodium berghei NK65.
    Niikura M; Kamiya S; Kita K; Kobayashi F
    J Immunol; 2008 May; 180(10):6877-84. PubMed ID: 18453608
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A malaria protein factor induces IL-4 production by dendritic cells via PI3K-Akt-NF-κB signaling independent of MyD88/TRIF and promotes Th2 response.
    Wu X; Gowda NM; Kawasawa YI; Gowda DC
    J Biol Chem; 2018 Jul; 293(27):10425-10434. PubMed ID: 29666186
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transgenic mice expressing human fetal globin are protected from malaria by a novel mechanism.
    Shear HL; Grinberg L; Gilman J; Fabry ME; Stamatoyannopoulos G; Goldberg DE; Nagel RL
    Blood; 1998 Oct; 92(7):2520-6. PubMed ID: 9746793
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Counter-regulatory anti-parasite cytokine responses during concurrent Plasmodium yoelii and intestinal helminth infections in mice.
    Noland GS; Urban JF; Fried B; Kumar N
    Exp Parasitol; 2008 Jun; 119(2):272-8. PubMed ID: 18396282
    [TBL] [Abstract][Full Text] [Related]  

  • 39. IFNAR1-Signalling Obstructs ICOS-mediated Humoral Immunity during Non-lethal Blood-Stage Plasmodium Infection.
    Sebina I; James KR; Soon MS; Fogg LG; Best SE; Labastida Rivera F; Montes de Oca M; Amante FH; Thomas BS; Beattie L; Souza-Fonseca-Guimaraes F; Smyth MJ; Hertzog PJ; Hill GR; Hutloff A; Engwerda CR; Haque A
    PLoS Pathog; 2016 Nov; 12(11):e1005999. PubMed ID: 27812214
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stromal cell derived factor 1 synthesis by spleen cells in rodent malaria, and the effects of in vivo supplementation of SDF-1alpha and CXCR4 receptor blocker.
    Garnica MR; Souto JT; Silva JS; de Andrade HF
    Immunol Lett; 2002 Aug; 83(1):47-53. PubMed ID: 12057854
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.